EPCAM and breast carcinoma: Two breast cancer cell lines, Hs578T and SKBR3, representing FAPα + CTCs (CTCFAPα) and EpCAM + CTCs (CTCEpCAM), respectively, were chosen to evaluate cell recovery and cross-reactivity using the dual selection strategy.